Immunoassay Analyzers Comprehensive Study by Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Allergy Testing, AIDS, Infectious Disease Testing, Others), Category (Benchtop Analyzers, Floor-standing Analyzers), Product Type (Immunoprecipitation, Immunonephelometry, Radioimmunoassay, Enzyme Immunoassay, Fluorescent Immunoassay, Chemiluminescent Immunoassays), End User (Hospitals, Diagnostic Laboratories, Research Institutes, Others) Players and Region - Global Market Outlook to 2030

Immunoassay Analyzers Market by XX Submarkets | Forecast Years 2024-2030  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Immunoassay Analyzers
Immunoassay analyzers are used to identify and detect the concentration of specific substances in a sample, usually using an antibody as a reagent. These devices can perform a variety of tests. They are used in clinical laboratories and in hospitals for determining protein, bacterial, or viral toxins, drug concentration, infectious diseases, testing allergy and endocrine hormones, and cardiac markers. The immunology analyzer uses certain chemical groups to label antigens or antibodies. The chemical group is oxidized to form an excited state, and in the process of returning to the ground state, it releases photons of a certain wavelength. The immunoassay analyzer market is poised for steady growth due to rising disease burdens, technological advancements, and a growing emphasis on personalized medicine. By addressing unmet needs and expanding into new markets, this sector can continue to play a vital role in global healthcare.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The immunoassay analyzers market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies’ focus related to the immunoassay analyzers market. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Immunoassay Analyzers market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

F. Hoffmann-La Roche Ltd (Switzerland), Siemens (Germany), Fujirebio (Japan), Agappe Diagnostics Ltd. (India), IDS Immunodiagnostic Systems (United Kingdom), Fapon (China), Thermo Fisher Scientific (United Kingdom), Immunodiagnostic Systems, Merck KGaA (Germany) and Olympus Corporation (Japan) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Trinity Biotech (Canada), Axion BioSystems, Inc (United States), Alfa Wassermann, Inc. (United States), Luminex Corporation (United States) and DiaSorin S.p.A. (Italy).

Segmentation Overview
AMA Research has segmented the market of Global Immunoassay Analyzers market by , Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Allergy Testing, AIDS, Infectious Disease Testing and Others) and Region.



On the basis of geography, the market of Immunoassay Analyzers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Category, the sub-segment i.e. Benchtop Analyzers will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Product Type, the sub-segment i.e. Immunoprecipitation will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Immunoassay Analyzers market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Shift Towards usage of chemiluminescence immunoassay (CLIA) and Rising awareness of early disease detection through screening programs

Market Growth Drivers:
Increasing demand for advanced diagnostic devices and Rising prevalence of chronic and infectious diseases

Challenges:
Stringent regulatory policies for product approvals and quality standards

Restraints:
The Immunoassay analyzer is highly expensive.

Opportunities:
Technological advancement towards the development of assays with higher sensitivities and Growing demand for personalized medicine

Market Leaders and their expansionary development strategies
In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd. announced that they have agreed with a Contract Development and Manufacturing Organization (CDMO) partnership for the Cartridge CLIA system reagents manufacturing project for the immunology equipment Mispa i60 and Mispa i121. Notably, the analyzers and reagents will be sold under Agappe’s brand, making Agappe the first Indian local company with a complete Chemiluminescence Solution comprising locally manufactured reagents.
In August 2023, Fapon launched its most efficient chemiluminescence immunoassay analyzer. The high-speed and fully automated analyzer has an ultra-high throughput of 900 tests per hour and features an integrated and compact design with stable performance. Its features a dual-tubes backup substrate system and automatic disposal of reaction cups to reduce contamination.


Key Target Audience
Manufacturing Companies, Research & Development Institutes, Market Research & Consultancy Firm, Potential Investors, Government & Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Allergy Testing
  • AIDS
  • Infectious Disease Testing
  • Others
By Category
  • Benchtop Analyzers
  • Floor-standing Analyzers

By Product Type
  • Immunoprecipitation
  • Immunonephelometry
  • Radioimmunoassay
  • Enzyme Immunoassay
  • Fluorescent Immunoassay
  • Chemiluminescent Immunoassays

By End User
  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing demand for advanced diagnostic devices
      • 3.2.2. Rising prevalence of chronic and infectious diseases
    • 3.3. Market Challenges
      • 3.3.1. Stringent regulatory policies for product approvals and quality standards
    • 3.4. Market Trends
      • 3.4.1. Growing Shift Towards usage of chemiluminescence immunoassay (CLIA)
      • 3.4.2. Rising awareness of early disease detection through screening programs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunoassay Analyzers, by Application, Category, Product Type, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Immunoassay Analyzers (Value)
      • 5.2.1. Global Immunoassay Analyzers by: Application (Value)
        • 5.2.1.1. Therapeutic Drug Monitoring
        • 5.2.1.2. Oncology
        • 5.2.1.3. Cardiology
        • 5.2.1.4. Allergy Testing
        • 5.2.1.5. AIDS
        • 5.2.1.6. Infectious Disease Testing
        • 5.2.1.7. Others
      • 5.2.2. Global Immunoassay Analyzers by: Category (Value)
        • 5.2.2.1. Benchtop Analyzers
        • 5.2.2.2. Floor-standing Analyzers
      • 5.2.3. Global Immunoassay Analyzers by: Product Type (Value)
        • 5.2.3.1. Immunoprecipitation
        • 5.2.3.2. Immunonephelometry
        • 5.2.3.3. Radioimmunoassay
        • 5.2.3.4. Enzyme Immunoassay
        • 5.2.3.5. Fluorescent Immunoassay
        • 5.2.3.6. Chemiluminescent Immunoassays
      • 5.2.4. Global Immunoassay Analyzers by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Laboratories
        • 5.2.4.3. Research Institutes
        • 5.2.4.4. Others
      • 5.2.5. Global Immunoassay Analyzers Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Immunoassay Analyzers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Siemens (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Fujirebio (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Agappe Diagnostics Ltd. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. IDS Immunodiagnostic Systems (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fapon (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Immunodiagnostic Systems
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck KGaA (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Olympus Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunoassay Analyzers Sale, by Application, Category, Product Type, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Immunoassay Analyzers (Value)
      • 7.2.1. Global Immunoassay Analyzers by: Application (Value)
        • 7.2.1.1. Therapeutic Drug Monitoring
        • 7.2.1.2. Oncology
        • 7.2.1.3. Cardiology
        • 7.2.1.4. Allergy Testing
        • 7.2.1.5. AIDS
        • 7.2.1.6. Infectious Disease Testing
        • 7.2.1.7. Others
      • 7.2.2. Global Immunoassay Analyzers by: Category (Value)
        • 7.2.2.1. Benchtop Analyzers
        • 7.2.2.2. Floor-standing Analyzers
      • 7.2.3. Global Immunoassay Analyzers by: Product Type (Value)
        • 7.2.3.1. Immunoprecipitation
        • 7.2.3.2. Immunonephelometry
        • 7.2.3.3. Radioimmunoassay
        • 7.2.3.4. Enzyme Immunoassay
        • 7.2.3.5. Fluorescent Immunoassay
        • 7.2.3.6. Chemiluminescent Immunoassays
      • 7.2.4. Global Immunoassay Analyzers by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Laboratories
        • 7.2.4.3. Research Institutes
        • 7.2.4.4. Others
      • 7.2.5. Global Immunoassay Analyzers Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunoassay Analyzers: by Application(USD Million)
  • Table 2. Immunoassay Analyzers Therapeutic Drug Monitoring , by Region USD Million (2018-2023)
  • Table 3. Immunoassay Analyzers Oncology , by Region USD Million (2018-2023)
  • Table 4. Immunoassay Analyzers Cardiology , by Region USD Million (2018-2023)
  • Table 5. Immunoassay Analyzers Allergy Testing , by Region USD Million (2018-2023)
  • Table 6. Immunoassay Analyzers AIDS , by Region USD Million (2018-2023)
  • Table 7. Immunoassay Analyzers Infectious Disease Testing , by Region USD Million (2018-2023)
  • Table 8. Immunoassay Analyzers Others , by Region USD Million (2018-2023)
  • Table 9. Immunoassay Analyzers: by Category(USD Million)
  • Table 10. Immunoassay Analyzers Benchtop Analyzers , by Region USD Million (2018-2023)
  • Table 11. Immunoassay Analyzers Floor-standing Analyzers , by Region USD Million (2018-2023)
  • Table 12. Immunoassay Analyzers: by Product Type(USD Million)
  • Table 13. Immunoassay Analyzers Immunoprecipitation , by Region USD Million (2018-2023)
  • Table 14. Immunoassay Analyzers Immunonephelometry , by Region USD Million (2018-2023)
  • Table 15. Immunoassay Analyzers Radioimmunoassay , by Region USD Million (2018-2023)
  • Table 16. Immunoassay Analyzers Enzyme Immunoassay , by Region USD Million (2018-2023)
  • Table 17. Immunoassay Analyzers Fluorescent Immunoassay , by Region USD Million (2018-2023)
  • Table 18. Immunoassay Analyzers Chemiluminescent Immunoassays , by Region USD Million (2018-2023)
  • Table 19. Immunoassay Analyzers: by End User(USD Million)
  • Table 20. Immunoassay Analyzers Hospitals , by Region USD Million (2018-2023)
  • Table 21. Immunoassay Analyzers Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 22. Immunoassay Analyzers Research Institutes , by Region USD Million (2018-2023)
  • Table 23. Immunoassay Analyzers Others , by Region USD Million (2018-2023)
  • Table 24. South America Immunoassay Analyzers, by Country USD Million (2018-2023)
  • Table 25. South America Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 26. South America Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 27. South America Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 28. South America Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 29. Brazil Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 30. Brazil Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 31. Brazil Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 32. Brazil Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 33. Argentina Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 34. Argentina Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 35. Argentina Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 36. Argentina Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 37. Rest of South America Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 38. Rest of South America Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 39. Rest of South America Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 40. Rest of South America Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 41. Asia Pacific Immunoassay Analyzers, by Country USD Million (2018-2023)
  • Table 42. Asia Pacific Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 43. Asia Pacific Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 44. Asia Pacific Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 45. Asia Pacific Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 46. China Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 47. China Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 48. China Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 49. China Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 50. Japan Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 51. Japan Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 52. Japan Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 53. Japan Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 54. India Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 55. India Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 56. India Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 57. India Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 58. South Korea Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 59. South Korea Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 60. South Korea Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 61. South Korea Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 62. Taiwan Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 63. Taiwan Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 64. Taiwan Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 65. Taiwan Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 66. Australia Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 67. Australia Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 68. Australia Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 69. Australia Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 74. Europe Immunoassay Analyzers, by Country USD Million (2018-2023)
  • Table 75. Europe Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 76. Europe Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 77. Europe Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 78. Europe Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 79. Germany Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 80. Germany Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 81. Germany Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 82. Germany Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 83. France Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 84. France Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 85. France Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 86. France Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 87. Italy Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 88. Italy Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 89. Italy Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 90. Italy Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 91. United Kingdom Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 92. United Kingdom Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 93. United Kingdom Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 94. United Kingdom Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 95. Netherlands Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 96. Netherlands Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 97. Netherlands Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 98. Netherlands Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 99. Rest of Europe Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 100. Rest of Europe Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 101. Rest of Europe Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 102. Rest of Europe Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 103. MEA Immunoassay Analyzers, by Country USD Million (2018-2023)
  • Table 104. MEA Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 105. MEA Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 106. MEA Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 107. MEA Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 108. Middle East Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 109. Middle East Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 110. Middle East Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 111. Middle East Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 112. Africa Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 113. Africa Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 114. Africa Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 115. Africa Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 116. North America Immunoassay Analyzers, by Country USD Million (2018-2023)
  • Table 117. North America Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 118. North America Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 119. North America Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 120. North America Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 121. United States Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 122. United States Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 123. United States Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 124. United States Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 125. Canada Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 126. Canada Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 127. Canada Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 128. Canada Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 129. Mexico Immunoassay Analyzers, by Application USD Million (2018-2023)
  • Table 130. Mexico Immunoassay Analyzers, by Category USD Million (2018-2023)
  • Table 131. Mexico Immunoassay Analyzers, by Product Type USD Million (2018-2023)
  • Table 132. Mexico Immunoassay Analyzers, by End User USD Million (2018-2023)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Immunoassay Analyzers: by Application(USD Million)
  • Table 144. Immunoassay Analyzers Therapeutic Drug Monitoring , by Region USD Million (2025-2030)
  • Table 145. Immunoassay Analyzers Oncology , by Region USD Million (2025-2030)
  • Table 146. Immunoassay Analyzers Cardiology , by Region USD Million (2025-2030)
  • Table 147. Immunoassay Analyzers Allergy Testing , by Region USD Million (2025-2030)
  • Table 148. Immunoassay Analyzers AIDS , by Region USD Million (2025-2030)
  • Table 149. Immunoassay Analyzers Infectious Disease Testing , by Region USD Million (2025-2030)
  • Table 150. Immunoassay Analyzers Others , by Region USD Million (2025-2030)
  • Table 151. Immunoassay Analyzers: by Category(USD Million)
  • Table 152. Immunoassay Analyzers Benchtop Analyzers , by Region USD Million (2025-2030)
  • Table 153. Immunoassay Analyzers Floor-standing Analyzers , by Region USD Million (2025-2030)
  • Table 154. Immunoassay Analyzers: by Product Type(USD Million)
  • Table 155. Immunoassay Analyzers Immunoprecipitation , by Region USD Million (2025-2030)
  • Table 156. Immunoassay Analyzers Immunonephelometry , by Region USD Million (2025-2030)
  • Table 157. Immunoassay Analyzers Radioimmunoassay , by Region USD Million (2025-2030)
  • Table 158. Immunoassay Analyzers Enzyme Immunoassay , by Region USD Million (2025-2030)
  • Table 159. Immunoassay Analyzers Fluorescent Immunoassay , by Region USD Million (2025-2030)
  • Table 160. Immunoassay Analyzers Chemiluminescent Immunoassays , by Region USD Million (2025-2030)
  • Table 161. Immunoassay Analyzers: by End User(USD Million)
  • Table 162. Immunoassay Analyzers Hospitals , by Region USD Million (2025-2030)
  • Table 163. Immunoassay Analyzers Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 164. Immunoassay Analyzers Research Institutes , by Region USD Million (2025-2030)
  • Table 165. Immunoassay Analyzers Others , by Region USD Million (2025-2030)
  • Table 166. South America Immunoassay Analyzers, by Country USD Million (2025-2030)
  • Table 167. South America Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 168. South America Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 169. South America Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 170. South America Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 171. Brazil Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 172. Brazil Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 173. Brazil Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 174. Brazil Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 175. Argentina Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 176. Argentina Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 177. Argentina Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 178. Argentina Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 179. Rest of South America Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 180. Rest of South America Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 181. Rest of South America Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 182. Rest of South America Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 183. Asia Pacific Immunoassay Analyzers, by Country USD Million (2025-2030)
  • Table 184. Asia Pacific Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 185. Asia Pacific Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 186. Asia Pacific Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 187. Asia Pacific Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 188. China Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 189. China Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 190. China Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 191. China Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 192. Japan Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 193. Japan Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 194. Japan Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 195. Japan Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 196. India Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 197. India Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 198. India Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 199. India Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 200. South Korea Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 201. South Korea Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 202. South Korea Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 203. South Korea Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 204. Taiwan Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 205. Taiwan Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 206. Taiwan Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 207. Taiwan Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 208. Australia Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 209. Australia Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 210. Australia Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 211. Australia Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 212. Rest of Asia-Pacific Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 213. Rest of Asia-Pacific Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 214. Rest of Asia-Pacific Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 216. Europe Immunoassay Analyzers, by Country USD Million (2025-2030)
  • Table 217. Europe Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 218. Europe Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 219. Europe Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 220. Europe Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 221. Germany Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 222. Germany Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 223. Germany Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 224. Germany Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 225. France Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 226. France Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 227. France Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 228. France Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 229. Italy Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 230. Italy Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 231. Italy Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 232. Italy Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 233. United Kingdom Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 234. United Kingdom Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 235. United Kingdom Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 236. United Kingdom Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 237. Netherlands Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 238. Netherlands Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 239. Netherlands Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 240. Netherlands Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 241. Rest of Europe Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 242. Rest of Europe Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 243. Rest of Europe Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 244. Rest of Europe Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 245. MEA Immunoassay Analyzers, by Country USD Million (2025-2030)
  • Table 246. MEA Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 247. MEA Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 248. MEA Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 249. MEA Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 250. Middle East Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 251. Middle East Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 252. Middle East Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 253. Middle East Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 254. Africa Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 255. Africa Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 256. Africa Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 257. Africa Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 258. North America Immunoassay Analyzers, by Country USD Million (2025-2030)
  • Table 259. North America Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 260. North America Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 261. North America Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 262. North America Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 263. United States Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 264. United States Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 265. United States Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 266. United States Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 267. Canada Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 268. Canada Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 269. Canada Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 270. Canada Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 271. Mexico Immunoassay Analyzers, by Application USD Million (2025-2030)
  • Table 272. Mexico Immunoassay Analyzers, by Category USD Million (2025-2030)
  • Table 273. Mexico Immunoassay Analyzers, by Product Type USD Million (2025-2030)
  • Table 274. Mexico Immunoassay Analyzers, by End User USD Million (2025-2030)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunoassay Analyzers: by Application USD Million (2018-2023)
  • Figure 5. Global Immunoassay Analyzers: by Category USD Million (2018-2023)
  • Figure 6. Global Immunoassay Analyzers: by Product Type USD Million (2018-2023)
  • Figure 7. Global Immunoassay Analyzers: by End User USD Million (2018-2023)
  • Figure 8. South America Immunoassay Analyzers Share (%), by Country
  • Figure 9. Asia Pacific Immunoassay Analyzers Share (%), by Country
  • Figure 10. Europe Immunoassay Analyzers Share (%), by Country
  • Figure 11. MEA Immunoassay Analyzers Share (%), by Country
  • Figure 12. North America Immunoassay Analyzers Share (%), by Country
  • Figure 13. Global Immunoassay Analyzers share by Players 2023 (%)
  • Figure 14. Global Immunoassay Analyzers share by Players (Top 3) 2023(%)
  • Figure 15. Global Immunoassay Analyzers share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 18. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2023
  • Figure 19. Siemens (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Siemens (Germany) Revenue: by Geography 2023
  • Figure 21. Fujirebio (Japan) Revenue, Net Income and Gross profit
  • Figure 22. Fujirebio (Japan) Revenue: by Geography 2023
  • Figure 23. Agappe Diagnostics Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 24. Agappe Diagnostics Ltd. (India) Revenue: by Geography 2023
  • Figure 25. IDS Immunodiagnostic Systems (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. IDS Immunodiagnostic Systems (United Kingdom) Revenue: by Geography 2023
  • Figure 27. Fapon (China) Revenue, Net Income and Gross profit
  • Figure 28. Fapon (China) Revenue: by Geography 2023
  • Figure 29. Thermo Fisher Scientific (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Thermo Fisher Scientific (United Kingdom) Revenue: by Geography 2023
  • Figure 31. Immunodiagnostic Systems Revenue, Net Income and Gross profit
  • Figure 32. Immunodiagnostic Systems Revenue: by Geography 2023
  • Figure 33. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Merck KGaA (Germany) Revenue: by Geography 2023
  • Figure 35. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Olympus Corporation (Japan) Revenue: by Geography 2023
  • Figure 37. Global Immunoassay Analyzers: by Application USD Million (2025-2030)
  • Figure 38. Global Immunoassay Analyzers: by Category USD Million (2025-2030)
  • Figure 39. Global Immunoassay Analyzers: by Product Type USD Million (2025-2030)
  • Figure 40. Global Immunoassay Analyzers: by End User USD Million (2025-2030)
  • Figure 41. South America Immunoassay Analyzers Share (%), by Country
  • Figure 42. Asia Pacific Immunoassay Analyzers Share (%), by Country
  • Figure 43. Europe Immunoassay Analyzers Share (%), by Country
  • Figure 44. MEA Immunoassay Analyzers Share (%), by Country
  • Figure 45. North America Immunoassay Analyzers Share (%), by Country
List of companies from research coverage that are profiled in the study
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Siemens (Germany)
  • Fujirebio (Japan)
  • Agappe Diagnostics Ltd. (India)
  • IDS Immunodiagnostic Systems (United Kingdom)
  • Fapon (China)
  • Thermo Fisher Scientific (United Kingdom)
  • Immunodiagnostic Systems
  • Merck KGaA (Germany)
  • Olympus Corporation (Japan)
Additional players considered in the study are as follows:
Trinity Biotech (Canada) , Axion BioSystems, Inc (United States) , Alfa Wassermann, Inc. (United States) , Luminex Corporation (United States) , DiaSorin S.p.A. (Italy)
Select User Access Type

Key Highlights of Report


Apr 2024 240 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as F. Hoffmann-La Roche Ltd (Switzerland), Siemens (Germany), Fujirebio (Japan), Agappe Diagnostics Ltd. (India), IDS Immunodiagnostic Systems (United Kingdom), Fapon (China), Thermo Fisher Scientific (United Kingdom), Immunodiagnostic Systems, Merck KGaA (Germany) and Olympus Corporation (Japan) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Shift Towards usage of chemiluminescence immunoassay (CLIA) " is seen as one of major influencing trends for Immunoassay Analyzers Market during projected period 2023-2030.
The Immunoassay Analyzers market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Immunoassay Analyzers Report?